Logos Capital
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
8Deep-tech portfolio3 active
5Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Avidity Biosciences
49Co-investorsShare a portfolio company
Portfolio · 8 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Disc Medicine | Biotech | Active | — | — |
| Expedition Therapeutics | Biotech | Active | — | — |
| Kymera Therapeutics | Biotech | Active | — | — |
| Avidity Biosciences | Biotech | Acquired | Mar 19, 2024 | $527.8M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Verve Therapeutics | Biotech | Acquired | Jan 22, 2021 | $94.0M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Pharvaris | Biotech | Public | — | — |
Peer ranks
Portfolio size#53
Portfolio exits#40
Raises, 12 months#88
Co-investors#29
Co-investors
- Biotechnology Value FundVenture capital5 shared
- EcoR1 CapitalVenture capital3 shared
- Foresite CapitalVenture capital3 shared
- Alexandria Venture InvestmentsVenture capital2 shared
- Apple Tree PartnersVenture capital2 shared
- Atlas VentureVenture capital2 shared
- Avoro Capital AdvisorsVenture capital2 shared
- Bay City CapitalVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Brookside CapitalVenture capital2 shared
Sectors
- Biotech8
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.